COMMUNIQUÉS West-GlobeNewswire

Acorn Health Expands Autism Diagnostic Evaluations in Florida
29/06/2026
CORAL GABLES, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Acorn Health, a leading provider of Applied Behavior Analysis (ABA) therapy, has expanded autism diagnostic services in Florida. Comprehensive diagnostic evaluations [...]
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
29/06/2026
FDA sets updated PDUFA date of December 27, 2026 BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision [...]
Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results
29/06/2026
Board-certified ophthalmologist and ASOPRS fellowship-trained surgeon Dr. Christopher I. Zoumalan, MD, FACS, explains how his trademarked Natural Looking Blepharoplasty® reflects the 2026 “less-is-more” movement in [...]
Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease
29/06/2026
IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26 FDA’s decision follows positive Phase 1 results for GT-02287 in both healthy volunteers and [...]
Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg
29/06/2026
New York, USA, June 29, 2026 (GLOBE NEWSWIRE) -- Dragon Pharma Store announced the addition of KLOW 80mg to its online research product catalog, reflecting continued expansion of available laboratory research materials [...]
Twentyeight Health partners with Clue to expand access to affordable birth control nationwide
29/06/2026
Bridging the gap between daily cycle tracking and provider-led contraceptive care for personalized reproductive health NEW YORK, June 29, 2026 (GLOBE NEWSWIRE) -- Twentyeight Health, the leading women's telehealth [...]
JellyFil Documents 2026 Supplement Facts Panel Composition, 8-Ingredient Proprietary Blend, and Manufacturing Disclosure for Its Gummy Dietary Supplement
29/06/2026
Once-daily men's gummy supplement featuring Maca, Ashwagandha, Tribulus, Arginine, Muira Puama, and Catuaba with 60-day money-back guarantee Largo, FL, June 29, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
PetVivo Reports Financial and Operational Results for Fiscal 2026
29/06/2026
MINNEAPOLIS, MN, US, June 29, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, [...]
Lakefront Receives Transparency Notification from Madison Avenue Partners
29/06/2026
Mechelen, Belgium; June 29, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) received a transparency notification from Madison Avenue Partners. Pursuant to Belgian [...]
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
29/06/2026
FORT LEE, NJ, June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement- [...]
Publication relative à des notifications de transparence
29/06/2026
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 29 juin 2026 , 22:30h CET / 17:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à [...]
DBV Technologies fait le point sur le dépôt du dossier BLA pour le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans; la Société travaille en collaboration avec la FDA afin d'optimiser le processus d'examen en vue du dépôt du dossier
29/06/2026
Châtillon, France, le 29 juin (22 :00 CEST) 2026 DBV Technologies fait le point sur le dépôt du dossier BLA pour le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans ; la Société travaille en collaboration avec [...]
Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition
29/06/2026
Acquisition Will Expand Patient Access, Strengthen Digital Healthcare Capabilities, and Create a Fully Vertically Integrated Medical Cannabis Framework for Tilray in Canada NEW YORK and TORONTO, June 29, 2026 (GLOBE [...]
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database
29/06/2026
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database [...]
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request
29/06/2026
Study designed to evaluate performance and formulation stability of proprietary nose-to-brain delivery system SARASOTA, FLA., June 29, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), a [...]
DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing
29/06/2026
Châtillon, France, June 29, 2026 DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in [...]
Publication relating to transparency notifications
29/06/2026
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), June 29, 2026 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the [...]
Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival
29/06/2026
Company Announcement Topline results from Phase 3 EPCORE ® DLBCL-4 evaluating epcoritamab in combination with lenalidomide demonstrated statistically significant and clinically meaningful improvement in progression-free [...]
Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
29/06/2026
Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité L’obéfazimod a apporté [...]

Pages